Cargando…

Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development

The extracellular matrix interacts with cancer cells and is a key factor in the development of cancer. Traditional two-dimensional models cannot mimic the natural in situ environment of cancer tissues, whereas three-dimensional (3D) models such as spherical culture, bioprinting, and microfluidic app...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruixin, Zhang, Chenghao, Li, Danxue, Yao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722735/
https://www.ncbi.nlm.nih.gov/pubmed/36483772
http://dx.doi.org/10.3389/fbioe.2022.1057913
_version_ 1784844020252409856
author Wang, Ruixin
Zhang, Chenghao
Li, Danxue
Yao, Yang
author_facet Wang, Ruixin
Zhang, Chenghao
Li, Danxue
Yao, Yang
author_sort Wang, Ruixin
collection PubMed
description The extracellular matrix interacts with cancer cells and is a key factor in the development of cancer. Traditional two-dimensional models cannot mimic the natural in situ environment of cancer tissues, whereas three-dimensional (3D) models such as spherical culture, bioprinting, and microfluidic approaches can achieve in vitro reproduction of certain structures and components of the tumor microenvironment, including simulation of the hypoxic environment of tumor tissue. However, the lack of a perfusable vascular network is a limitation of most 3D models. Solid tumor growth and metastasis require angiogenesis, and tumor models with microvascular networks have been developed to better understand underlying mechanisms. Tumor-on-a-chip technology combines the advantages of microfluidics and 3D cell culture technology for the simulation of tumor tissue complexity and characteristics. In this review, we summarize progress in constructing tumor-on-a-chip models with efficiently perfused vascular networks. We also discuss the applications of tumor-on-a-chip technology to studying the tumor microenvironment and drug development. Finally, we describe the creation of several common tumor models based on this technology to provide a deeper understanding and new insights into the design of vascularized cancer models. We believe that the tumor-on-a-chip approach is an important development that will provide further contributions to the field.
format Online
Article
Text
id pubmed-9722735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97227352022-12-07 Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development Wang, Ruixin Zhang, Chenghao Li, Danxue Yao, Yang Front Bioeng Biotechnol Bioengineering and Biotechnology The extracellular matrix interacts with cancer cells and is a key factor in the development of cancer. Traditional two-dimensional models cannot mimic the natural in situ environment of cancer tissues, whereas three-dimensional (3D) models such as spherical culture, bioprinting, and microfluidic approaches can achieve in vitro reproduction of certain structures and components of the tumor microenvironment, including simulation of the hypoxic environment of tumor tissue. However, the lack of a perfusable vascular network is a limitation of most 3D models. Solid tumor growth and metastasis require angiogenesis, and tumor models with microvascular networks have been developed to better understand underlying mechanisms. Tumor-on-a-chip technology combines the advantages of microfluidics and 3D cell culture technology for the simulation of tumor tissue complexity and characteristics. In this review, we summarize progress in constructing tumor-on-a-chip models with efficiently perfused vascular networks. We also discuss the applications of tumor-on-a-chip technology to studying the tumor microenvironment and drug development. Finally, we describe the creation of several common tumor models based on this technology to provide a deeper understanding and new insights into the design of vascularized cancer models. We believe that the tumor-on-a-chip approach is an important development that will provide further contributions to the field. Frontiers Media S.A. 2022-11-22 /pmc/articles/PMC9722735/ /pubmed/36483772 http://dx.doi.org/10.3389/fbioe.2022.1057913 Text en Copyright © 2022 Wang, Zhang, Li and Yao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Wang, Ruixin
Zhang, Chenghao
Li, Danxue
Yao, Yang
Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title_full Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title_fullStr Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title_full_unstemmed Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title_short Tumor-on-a-chip: Perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
title_sort tumor-on-a-chip: perfusable vascular incorporation brings new approach to tumor metastasis research and drug development
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722735/
https://www.ncbi.nlm.nih.gov/pubmed/36483772
http://dx.doi.org/10.3389/fbioe.2022.1057913
work_keys_str_mv AT wangruixin tumoronachipperfusablevascularincorporationbringsnewapproachtotumormetastasisresearchanddrugdevelopment
AT zhangchenghao tumoronachipperfusablevascularincorporationbringsnewapproachtotumormetastasisresearchanddrugdevelopment
AT lidanxue tumoronachipperfusablevascularincorporationbringsnewapproachtotumormetastasisresearchanddrugdevelopment
AT yaoyang tumoronachipperfusablevascularincorporationbringsnewapproachtotumormetastasisresearchanddrugdevelopment